|
|
||||||||
Journal of Lipid Research, Vol 26, 26-37, Copyright © 1985 by Lipid Research, Inc.
RB Weinberg and MS Spector
Human apolipoprotein A-IV rapidly dissociates from the surface of lymph
chylomicrons following their entry into circulation by an unknown
mechanism. We have therefore investigated the binding of human apoA-IV to
triglyceride-rich particles and the interaction of these apoA- IV/lipid
complexes with human HDL2. Human apoA-IV was purified from lipoprotein
depleted serum (J. Lipid Res. 1983. 24:52-59). Triglyceride- rich particles
of well-defined properties were isolated from Intralipid, a commercially
available phospholipid-triglyceride emulsion. Various concentrations of
radiolabeled human apoA-IV were incubated at 24 degrees C with a fixed
quantity of lipid particles; the particles were reisolated by
centrifugation, and bound and free apoA-IV were quantitated. In 50 mM Tris,
pH 7.4, apoA-IV bound to the triglyceride-rich particles in a
non-cooperative manner, with a Kd of 2.0 microM. The calculated maximal
binding was 4.96 X 10(-4) mol of apoA-IV bound per mol of phospholipid. The
addition of increasing amounts of human HDL2 to the incubations caused the
progressive dissociation of apoA-IV from the triglyceride-rich particles.
Analysis of the reisolated particles by isoelectric focusing demonstrated
the presence of C-apoproteins, suggesting their transfer from HDL2.
Addition of purified apoC-III-1 to the incubations at concentrations
equivalent to those present in HDL2 caused a similar dissociation of
apoA-IV. HDL2 was modified to selectively remove C-apoproteins, without
alteration of other physical characteristics. This modified HDL2 was four
times less effective in causing apoA-IV dissociation. These results
demonstrate that the lipid binding properties of human apoA-IV may be
quantitatively examined using triglyceride-rich particles as model
chylomicrons. This approach reproduces in vitro the dissociation of apoA-IV
that occurs in vivo when mesenteric lymph chylomicrons enter the
circulation, and suggests that the primary mechanism for this phenomenon is
the transfer of C-apoproteins from high density lipoproteins to the
triglyceride-rich particle surface. We hypothesize that this mechanism may
play an important role in the modulation of chylomicron apoA-IV content in
man.
ARTICLES
Human apolipoprotein A-IV: displacement from the surface of triglyceride-rich particles by HDL2-associated C-apoproteins
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. R. Tubb, R. A. G. D. Silva, J. Fang, P. Tso, and W. S. Davidson A Three-dimensional Homology Model of Lipid-free Apolipoprotein A-IV Using Cross-linking and Mass Spectrometry J. Biol. Chem., June 20, 2008; 283(25): 17314 - 17323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Tubb, R. A. G. D. Silva, K. J. Pearson, P. Tso, M. Liu, and W. S. Davidson Modulation of Apolipoprotein A-IV Lipid Binding by an Interaction between the N and C Termini J. Biol. Chem., September 28, 2007; 282(39): 28385 - 28394. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Spaulding, F. Saijo, R. H. Turnage, J. S. Alexander, T. Y. Aw, and T. J. Kalogeris Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance Am J Physiol Cell Physiol, January 1, 2006; 290(1): C95 - C103. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gotoh, M. Liu, S. C. Benoit, D. J. Clegg, W. S. Davidson, D. D'Alessio, R. J. Seeley, P. Tso, and S. C. Woods Apolipoprotein A-IV interacts synergistically with melanocortins to reduce food intake Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R202 - R207. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pearson, M. R. Tubb, M. Tanaka, X. Q. Zhang, P. Tso, R. B. Weinberg, and W. S. Davidson Specific Sequences in the N and C Termini of Apolipoprotein A-IV Modulate Its Conformation and Lipid Association J. Biol. Chem., November 18, 2005; 280(46): 38576 - 38582. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Aouizerat, M. Kulkarni, D. Heilbron, D. Drown, S. Raskin, C. R. Pullinger, M. J. Malloy, and J. P. Kane Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids J. Lipid Res., June 1, 2003; 44(6): 1167 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Weinberg, R. A. Anderson, V. R. Cook, F. Emmanuel, P. Denefle, A. R. Tall, and A. Steinmetz Interfacial Exclusion Pressure Determines the Ability of Apolipoprotein A-IV Truncation Mutants to Activate Cholesterol Ester Transfer Protein J. Biol. Chem., June 7, 2002; 277(24): 21549 - 21553. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sun, F. K Welty, G. G Dolnikowski, A. H Lichtenstein, and E. J Schaefer Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma Am. J. Clinical Nutrition, September 1, 2001; 74(3): 308 - 314. [Abstract] [Full Text] |
||||
![]() |
M. Liu, T. Doi, L. Shen, S. C. Woods, R. J. Seeley, S. Zheng, A. Jackman, and P. Tso Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1382 - R1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Hockey, R. A. Anderson, V. R. Cook, R. R. Hantgan, and R. B. Weinberg Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance J. Lipid Res., February 1, 2001; 42(2): 211 - 217. [Abstract] [Full Text] |
||||
![]() |
R. B. Weinberg, R. A. Anderson, V. R. Cook, F. Emmanuel, P. Denefle, M. Hermann, and A. Steinmetz Structure and interfacial properties of chicken apolipoprotein A-IV J. Lipid Res., September 1, 2000; 41(9): 1410 - 1418. [Abstract] [Full Text] |
||||
![]() |
R. B. Weinberg, V. R. Cook, J. A. DeLozier, and G. S. Shelness Dynamic interfacial properties of human apolipoproteins A-IV and B-17 at the air/water and oil/water interface J. Lipid Res., September 1, 2000; 41(9): 1419 - 1427. [Abstract] [Full Text] |
||||
![]() |
E. D. Breyer, N.-A. Le, X. Li, D. Martinson, and W. V. Brown Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size J. Lipid Res., October 1, 1999; 40(10): 1875 - 1882. [Abstract] [Full Text] |
||||
![]() |
M. A. Ostos, J. Lopez-Miranda, J. M. Ordovas, C. Marin, A. Blanco, P. Castro, F. Lopez-Segura, J. Jimenez-Pereperez, and F. Perez-Jimenez Dietary fat clearance is modulated by genetic variation in apolipoprotein A-IV gene locus J. Lipid Res., December 1, 1998; 39(12): 2493 - 2500. [Abstract] [Full Text] |
||||
![]() |
S. Jansen, J. Lopez-Miranda, J. Salas, J. M. Ordovas, P. Castro, C. Marin, M. A. Ostos, F. Lopez-Segura, J. A. Jimenez-Pereperez, A. Blanco, et al. Effect of 347-Serine Mutation in Apoprotein A-IV on Plasma LDL Cholesterol Response to Dietary Fat Arterioscler. Thromb. Vasc. Biol., August 1, 1997; 17(8): 1532 - 1538. [Abstract] [Full Text] |
||||
![]() |
R. J. McCombs, D. E. Marcadis, J. Ellis, and R. B. Weinberg Attenuated Hypercholesterolemic Response to a High-Cholesterol Diet in Subjects Heterozygous for the Apolipoprotein A-IV-2 Allele N. Engl. J. Med., September 15, 1994; 331(11): 706 - 710. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |